Evidence map›Paper›PMID 41224206›Full record

ArticleDiabetes & metabolism journal2026

LRRFIP1 Inhibits White Adipocyte Differentiation by Suppressing the E2F6/C/EBPα Axis.

Lei Zhou, Yuwen Jiao, Jiaming Xue, Xiaoqiang Zhan, Dongmei Wang, Liming Tang

Abstract read
In one paragraph

Article in Diabetes & metabolism journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lei Zhou *The Graduate School, Dalian Medical University, Dalian, China.
Yuwen Jiao *The Graduate School, Dalian Medical University, Dalian, China.
Jiaming Xue *The Graduate School, Dalian Medical University, Dalian, China.
Xiaoqiang ZhanDepartment of Science and Technology, Jiangsu Medical Vocational College, Yancheng, China.
Dongmei WangDepartment of Gastrointestinal Surgery, Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, China. dmwang@njmu.edu.cn.
Liming TangThe Graduate School, Dalian Medical University, Dalian, China. drtangliming@163.com.

Funding

Changzhou Sci and Tech Program 2022CZLJ017Changzhou Sci and Tech Program LC20242022CZLJ017Changzhou Sci and Tech Program QY202306Clinical Teaching Hospitals of Jiangsu Vocational College of Medicine 20229121College-local collaborative innovation research project of Jiangsu Vocational College of Medicine 202490110Natural Science Foundation of Jiangsu Province BK20241775Yan cheng Municipal Health Commission YK2023021
6 · The paper itself

Abstract

backgruoundTo investigate the biological functions of the transcription factor LRR binding FLII interacting protein 1 (LRRFIP1) in white adipocyte differentiation (WAD) and elucidate the underlying molecular regulatory mechanisms involved.

methodsConsensus clustering, differential gene expression screening, and intersection analysis were used to identify transcription factors involved in WAD. Adipogenic differentiation experiments were conducted using C3H10T1/2 cells, and a diet-induced obesity model in C57BL/6J mice was established to investigate the function of LRRFIP1 in WAD in vitro and in vivo. Molecular mechanisms were examined through quantitative real-time polymerase chain reaction, Western blotting, luciferase assays, and chromatin immunoprecipitation.

resultsBioinformatics analyses identified LRRFIP1 as a transcription factor associated with WAD. LRRFIP1 expression was downregulated in white adipose tissues from obese patients and in mature white adipocytes. Silencing LRRFIP1 significantly inhibited WAD in C3H10T1/2 cells and reduced differentiation biomarker expression; in contrast, overexpressing LRRFIP1 had the opposite effects. Mechanistically, LRRFIP1 bound to the E2F transcription factor 6 (E2F6) promoter to suppress E2F6 transcription, thereby downregulating a key differentiation regulator, CCAAT enhancer binding protein alpha (C/EBPα). Furthermore, in a diet-induced obesity model, LRRFIP1 could regulate the differentiation and maturation of inguinal white adipose tissue.

conclusionOur findings reveal that LRRFIP1 plays a crucial inhibitory role in WAD by negatively regulating the E2F6/C/EBPα axis. This discovery not only enriches our understanding of the molecular networks governing WAD but also holds great promise for creating targeted therapies for obesity and associated metabolic conditions.

Indexed as

Adipocytes, WhiteAdipogenesisCCAAT-Enhancer-Binding Protein-alphaCell DifferentiationAnimalsDown-RegulationHumansMaleMiceMice, Inbred C57BLObesityCCAAT-Enhancer-Binding Protein-alphaAdipocytes, whiteCell differentiationLRRFIP1 protein, humanObesityTranscription factors

Identifiers

PMID41224206
PMCPMC13561650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.